LOUISVILLE, Ky. (WDRB) -- Baptist Health Hardin has become the first hospital in the world to begin human trials of new breast imaging technology to detect cancer.
The investigational 4D Mammography device reads molecular level "fingerprints" in tissue, developed by Calidar Inc.
In this first in-human study, researchers will test the technology's potential ability to identify cancer earlier and more accurately.
The trial launched Tuesday with the successful imaging of the first patient using the 4D Mammography system.
Unlike traditional x-ray images, which rely on shape and density, this technology reveals what the tissue is made of.
"So the 4D, we've also been describing it as it's bringing color to X-ray images," Stefan Stryker, CEO of Calidar Inc., said. "This type of new scatter data adds like a new full channel of measurements and so for physicians, this looks like being able to look at tissue with a colorized pattern."
The first clinical trial is expected to enroll approximately 60 patients over the next several months.
To learn more, click here.
Top Stories:
Louisville jail mistakenly releases defendant deemed a 'significant danger'
Louisville Belvedere plan shifts ‘wow moment’ from Ohio River overlook due to cost concern
Quick action by Jeffersonville school workers helps student survive cardiac arrest
Man accused of beheading father in Jeffersonville held without bond after initial hearing
Copyright 2025 WDRB Media. All Rights Reserved.
